Liza Elsayed Ali
Zagazig, Sharquia, 33735, Egypt
NCT Number: NCT04078620
Drug drug interactions is frequent in critically ill patients due to polypharmacy, different drug groups and prolonged ICU or hospital stay
Looking for future studies?
Notify MeAll sexes
Observational
Zagazig, Sharquia, 33735, Egypt
This cross sectional study was conducted in Surgical ICU, zagazig University Hospital for 6months period.
Demographic data (age, gender),clinical history data (main diagnosis, ICU stay in days, transfer from emergency room or other departments, on mechanical ventilation or not, state of consciousness
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Survey for drug drug interactions on Medscape and Lexicomp interaction checker applications
Time frame: 6months period
Lexicomp interactions classified As:
A(no known interactions) B(no action needed) C(monitor therapy) D(consider therapy modification) X (avoid combination)
Time frame: 6months period
Interactions classified with Medescape interactions checker as :(contraindicated, serious use alternative, monitor closely,minor)
Zagazig University
Other Gov
Risk Factors for Potential Drug -Drug Interactions: Study in Surgical Intensive Care Unit -Zagazig University Hospitals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06566794
Drug Interaction
Helsinki, Finland
View Trial DetailsNCT07308041
Deglutition Disorders, Digestive System Diseases
Uppsala, Sweden
View Trial DetailsNCT06930872
Drug Interaction
Adelaide, South Australia, Australia
View Trial DetailsNCT04463576
Drug Interaction
Bordeaux, France
View Trial Details